Celemics, Inc. is a pioneering company in the Next Generation Sequencing (NGS) field, founded in 2010. With a focus on advanced enzymes, reagents, probes, and bioinformatics solutions, Celemics provides exceptional quality products and services that meet ISO-certified standards. Serving customers across over 54 countries, Celemics offers optimized NGS solutions that drive new insights in various fields, including clinical research, viral and pathogen research, and drug development.
The company's offerings include Library Preparation Kits, NGS Target Enrichment Panels, Bioinformatics Analysis, and NGS Services. These solutions support key areas such as Laboratory Developed Tests (LDTs), clinical research, viral and pathogen research, agrigenomics, drug development, and more. Celemics' major clients include hospitals and clinical laboratories, government and research institutions, agricultural institutions, and biopharma, CROs, and biotech companies.
Headquartered in Seoul with offices in the U.S. and India, Celemics is committed to advancing research and innovation in the NGS field. The company's strategic approach to quality and customer service has made it a trusted partner for organizations seeking cutting-edge NGS solutions.
B2B professionals would contact Celemics, Inc. for their cutting-edge NGS solutions and exceptional quality products. The company's comprehensive range of services and global presence make it an ideal partner for organizations seeking to advance their research and development efforts in the NGS field.
Sales teams selling NGS solutions, recruiters seeking roles in the biotech and pharmaceutical industries, and partners offering bioinformatics and NGS services should reach out to Celemics, Inc.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Celemics, Inc.